Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 7, 2006 - Issue 3
Submit an article Journal homepage
249
Views
6
CrossRef citations to date
0
Altmetric
CASE REPORT

Sulbutiamine, an ‘innocent’ over the counter drug, interferes with therapeutic outcome of bipolar disorder

Athanasios Douzenis Department of General Hospital Psychiatry, Athens University Medical School, ‘Attikon’ Hospital, Athens, Greece
,
Ioannis Michopoulos Department of General Hospital Psychiatry, Athens University Medical School, ‘Attikon’ Hospital, Athens, Greece
&
Lefteris Lykouras Department of General Hospital Psychiatry, Athens University Medical School, ‘Attikon’ Hospital, Athens, GreeceCorrespondence[email protected]
, FICPM , MD , PhD
Pages 183-185 | Received 14 Jul 2005, Published online: 12 Jul 2009

References

  • Balzamo E, Vuillon-Cacciuttolo G. Facilitation of a state of wakefulness by semi-chronic treatment with sulbutiamine (Arcalion) in Macaca mulatta. Rev Electroencephalogr Neurophysiol Clin 1982; 12: 373–378
  • Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001; 3: 181–188
  • Council on Scientific Affairs. Vitamin preparations as dietary supplements and as therapeutic agents. J Am Med Assoc ;257 1987; 10(14)1929–1936
  • Loo H, Poirier MF, Ollat H, Elatki S. Effects of sulbutiamine (Arcalion 200) on psycho-behavioral inhibition in major depressive episodes. Encephale 2000; 26: 70–75
  • Mamtani R, Cimino A. A primer of complementary and alternative medicine and its relevance in the treatment of mental health problems. Psychiatr Q 2002; 73: 367–381
  • Micheau J, Durkin TP, Destrade C, Rolland Y, Jaffard R. Chronic administration of sulbutiamine improves long term memory formation in mice: Possible cholinergic mediation. Pharmacol Biochem Behav 1985; 23: 195–198
  • Morra M, Philipszoon HD, D'Andrea G, Cananzi AR, L'Erario R, Milone FF. Sensory and motor neuropathy caused by excessive ingestion of vitamin B6: a case report. Funct Neurol 1993; 8: 429–432
  • Shah SN; Sulbutiamine Study Group. 2003. Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia. J Assoc Phys India 51:891–895.
  • Sonne SC, Brady KT. Substance abuse and bipolar comorbidity. Psychiatr Clin North Am 1999; 22: 609–627, , ix
  • Strakowski SM, DelBello MP. The co-occurrence of bipolar and substance use disorders. Clin Psychol Rev 2000; 20: 191–206
  • Trovero F, Gobbi M, Weil-Fuggaza J, Besson MJ, Brochet D, Pirot S. Evidence for a modulatory effect of sulbutiamine on glutamatergic and dopaminergic cortical transmissions in the rat brain. Neurosci Lett ;292 2000; 29(1)49–53
  • Van Reeth O. Pharmacologic and therapeutic features of sulbutiamine. Drugs Today (Barc) 1999; 35: 187–192
  • World Health Organization. The ICD-10. Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. World Health Organization, Geneva 1993

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.